Loading...
 
Register Log In Login with facebook

Pancreatic cancer risk of death reduced 19 percent by Vitamin D – meta-analysis June 2017

Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis.

Oncotarget. 2017 Jun 29. doi: 10.18632/oncotarget.18888. [Epub ahead of print]
Zhang X1, Huang XZ1, Chen WJ1, Wu J1, Chen Y2, Wu CC1, Wang ZN3.

VitaminDWiki Summary

21% reduction in deaths, but no reduction in occurrence (study on this page)

That is, high Vitamin D blood level does not change who gets pancreatic caner, but it does increase survival

Note: Like many other diseases, how much vitamin D actually gets to the cells is far more important that how much is in blood

See also VitaminDWiki

Vitamin D Receptor category has the following

173 items in Vitamin D Receptor category

Vitamin D tests cannot detect Vitamin D Receptor (VDR) problems
A poor VDR restricts Vitamin D from getting in the cells
A poor VDR increases the risk of 37 health problems  click here for details

VDR at-home test $29 - results not easily understood in 2016
There are hints that you may have inherited a poor VDR
You can compensate for poor VDR by increasing one or more of the following:

IncreasingIncreases
1) Vitamin D supplement
  Sun, Ultraviolet -B
Vitamin D in the blood
and thus to the cells
2) MagnesiumVitamin D in the blood
 AND to the cells
3) Omega-3 Vitamin D to the cells
4) Resveratrol Vitamin D to the cells
5) Intense exercise Vitamin D Receptor
6) Get prescription for VDR activator
   paricalcitol, maxacalcitol?
Vitamin D Receptor
7) Quercetin (flavonoid) Vitamin D Receptor

Genetics category listing contains the following

Many genes are NOT noticed by Vitamin D blood tests
Image


 Download the PDF from VitaminDWiki

Pancreatic cancer MORTALITY

Image

Pancreatic cancer INCIDENCE

Image

BACKGROUND:
The associations between vitamin D status, including plasma 25-hydroxyvitamin D [25(OH)D] levels and vitamin D intake, and pancreatic cancer risk and mortality are inconsistent. The aims of this study are to evaluate the antitumor and therapeutic effects of vitamin D status for pancreatic cancer patients.

METHODS:
A literature search for relevant studies was conducted using PubMed and Embase databases. Risk ratio (RR), hazard ratio (HR), and 95% confidence interval (CI) were used as the effect measures. All statistical analyses were performed using Stata software 12.0.

ESULTS:
Our results indicated that high plasma 25(OH)D levels were inversely associated with pancreatic cancer mortality without significant heterogeneity (HR=0.81, 95% CI=0.68-0.96). However, high plasma 25(OH)D levels could not reduce pancreatic cancer risk (RR=1.02, 95% CI=0.66-1.57). Moreover, vitamin D intake was also not associated with pancreatic cancer risk (RR=1.11, 95% CI=0.67-1.86)

Conclusions: Our results indicate that high plasma 25(OH)D levels were significantly associated with improved survival in pancreatic cancer patients. However, there were no significant associations between vitamin D intake or plasma 25(OH)D levels and pancreatic cancer risk.

PMID: 28733547 DOI: 10.18632/oncotarget.18888

Created by admin. Last Modification: Tuesday July 25, 2017 16:09:08 UTC by admin. (Version 9)

Attached files

ID Name Comment Uploaded Size Downloads
8209 PC risk.jpg admin 25 Jul, 2017 15:27 41.87 Kb 69
8208 PC mortality.jpg admin 25 Jul, 2017 15:27 38.21 Kb 58
8207 pancreatic cancer mortality.pdf PDF 2017 admin 25 Jul, 2017 15:26 1.81 Mb 35
See any problem with this page? Report it to the webmaster.